Document:

EX-10.3

 Exhibit 10.3 

PRIVATE PLACEMENT WARRANTS PURCHASE AGREEMENT 

THIS PRIVATE PLACEMENT WARRANTS PURCHASE AGREEMENT, dated as of [•], 2021 (as it may from time to time be amended and including all
exhibits referenced herein, this “Agreement”), is entered into by and between Gefen Landa Acquisition Corp., a Cayman Islands exempted company (the “Company”), and the undersigned (each a
“Purchaser”, and collectively, the “Purchasers”). 
 WHEREAS: 

The Company intends to consummate an initial public offering (the “Public Offering”) of the Company’s units (the
“Units”), each Unit consisting of one Class A ordinary share of the Company, par value $0.0001 per share (each, an “Ordinary Share”), and one-third of one redeemable
warrant; and 
 Each whole warrant entitles the holder to purchase from the Company one Ordinary Share at an exercise price of $11.50 per
Ordinary Share; and the Purchasers have agreed to purchase, at a price of $1.50 per warrant, an aggregate of 4,666,667 warrants (or up to 5,166,667 warrants depending on the extent to which the underwriters in the Public Offering exercise their
over-allotment option to purchase additional Units as part of the Public Offering in full) (the “Private Placement Warrants”), each Private Placement Warrant entitling the holder to purchase one Ordinary Share at an exercise price
of $11.50 per Ordinary Share, in such amounts as described on Exhibit A hereto. 
 NOW THEREFORE, in consideration of the mutual
promises contained in this Agreement and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties to this Agreement hereby, intending legally to be bound, agree as follows: 

AGREEMENT 

Section 1. Authorization, Purchase and Sale; Terms of the Private Placement Warrants. 

A. Authorization of the Private Placement Warrants. The Company has duly authorized the issuance and sale of the Private Placement
Warrants to the Purchasers. 
 B. Purchase and Sale of the Private Placement Warrants. 

(i) On the date of the consummation of the Public Offering or on such earlier time and date as may be mutually agreed by each Purchaser and the
Company (the “Initial Closing Date”), the Company shall issue and sell to each Purchaser, and the Purchasers shall purchase from the Company, 4,666,667 Private Placement Warrants at a price of $1.50 per warrant for an aggregate
purchase price of $7,000,000.00 (the “Purchase Price”) (in such amounts as described on Exhibit A hereto), which shall be paid by wire transfer of immediately available funds to the Company at least one day prior to the
Initial Closing Date in accordance with the Company’s wiring instructions or by such other method as may be reasonably acceptable to the Company, to the trust account (the “Trust Account”) maintained by American Stock
Transfer & Trust Company, LLC, acting as trustee, on the Initial Closing Date. On the Initial Closing Date, following the payment by the Purchasers of the Purchase Price by wire transfer of immediately available funds to the Trust Account,
the Company shall effect the delivery of the Private Placement Warrants in book-entry form. 

 (ii) On the date of any closing of the over-allotment option, if any, in connection with the
Public Offering or on such earlier time and date as may be mutually agreed by the Purchasers and the Company (each such date, an “Over-allotment Closing Date,” and each Over-allotment Closing Date (if any) and the Initial Closing
Date being sometimes referred to herein as a “Closing Date”), the Company shall issue and sell to the Purchasers, and the Purchasers shall purchase from the Company, up to an aggregate of 500,000 Private Placement Warrants (the
“Additional Private Placement Warrants”), in the same proportion as the amount of the option that is then so exercised, at a price of $1.50 per warrant for an aggregate purchase price of up to $750,000 (if the over-allotment option
in connection with the Public Offering is exercised in full) (the “Over-allotment Purchase Price”) (in such amounts as described on Exhibit A hereto), which shall be paid by wire transfer or by such other method as may be
reasonably acceptable to the Company of immediately available funds to the Trust Account at least one day prior to such Over-allotment Closing Date in accordance with the Company’s wiring instructions. On the Over-allotment Closing Date,
following the payment by the Purchasers of the Over-allotment Purchase Price by wire transfer or by such other method as may be reasonably acceptable to the Company of immediately available funds to the Trust Account, the Company, at its option,
shall effect the delivery of the Additional Private Placement Warrants in book-entry form. 
 C. Terms of the Private Placement
Warrants. 
 (i) Each Private Placement Warrant shall have the terms set forth in a Warrant Agreement to be entered into by the Company
and a warrant agent, in connection with the Public Offering (a “Warrant Agreement”) and shall be subject to the terms of a letter agreement to be entered into by the Company, the Purchasers and the other parties thereto in
connection with the Public Offering. 
 (ii) At the time of, or prior to, the closing of the Public Offering, the Company and the Purchasers
shall enter into a registration rights agreement (the “Registration Rights Agreement”) pursuant to which the Company will grant certain registration rights to the Purchasers relating to the Private Placement Warrants and the
Ordinary Shares underlying the Private Placement Warrants. 
 Section 2. Representations and Warranties of the Company. As a
material inducement to the Purchasers to enter into this Agreement and purchase the Private Placement Warrants, the Company hereby represents and warrants to the Purchasers (which representations and warranties shall survive each Closing Date) that:

 A. Organization and Corporate Power. The Company is an exempted company duly incorporated, validly existing and in good standing
under the laws of the Cayman Islands and is qualified to do business in every jurisdiction in which the failure to so qualify would reasonably be expected to have a material adverse effect on the financial condition, operating results or assets of
the Company. The Company possesses all requisite corporate power and authority necessary to carry out the transactions contemplated by this Agreement and the Warrant Agreement. 

  
 2 

 B. Authorization; No Breach. 

(i) The execution, delivery and performance of this Agreement and the Private Placement Warrants have been duly authorized by the Company as of
each Closing Date. This Agreement constitutes the valid and binding obligation of the Company, enforceable in accordance with its terms. Upon issuance in accordance with, and payment pursuant to, the terms of the Warrant Agreement and this
Agreement, the Private Placement Warrants will constitute valid and binding obligations of the Company, enforceable in accordance with their terms as of each Closing Date. 

(ii) The execution and delivery by the Company of this Agreement and the Private Placement Warrants, the issuance and sale of the Private
Placement Warrants, the issuance of the Ordinary Shares upon exercise of the Private Placement Warrants and the fulfillment, of and compliance with, the respective terms hereof and thereof by the Company, do not and will not as of each Closing Date
(a) conflict with or result in a breach of the terms, conditions or provisions of, (b) constitute a default under, (c) result in the creation of any lien, security interest, charge or encumbrance upon the Company’s share capital
or assets under, (d) result in a violation of, or (e) require any authorization, consent, approval, exemption or other action by or notice or declaration to, or filing with, any court or administrative or governmental body or agency
pursuant to, the amended and restated memorandum and articles of association of the Company (in effect on the date hereof or as may be amended prior to completion of the Public Offering), or any material law, statute, rule or regulation to which the
Company is subject, or any agreement, order, judgment or decree to which the Company is subject, except for any filings required after the date hereof under federal or state securities laws. 

C. Title to Securities. Upon issuance in accordance with, and payment pursuant to, and registration in the register of members of the
Company, the terms hereof and the Warrant Agreement, the Ordinary Shares issuable upon exercise of the Private Placement Warrants will be duly and validly issued, fully paid and non-assessable. On the date of
issuance of the Private Placement Warrants, the Ordinary Shares issuable upon exercise of the Private Placement Warrants shall have been reserved for issuance. Upon issuance in accordance with, and payment pursuant to, the terms hereof and the
Warrant Agreement and the Memorandum and Articles of Association, and upon registration in the Company’s register of members, the Purchasers will have good title to the Private Placement Warrants and the Ordinary Shares issuable upon exercise
of such Private Placement Warrants, free and clear of all liens, claims and encumbrances of any kind, other than (i) transfer restrictions hereunder and under the other agreements contemplated hereby, (ii) transfer restrictions under
federal and state securities laws, and (iii) liens, claims or encumbrances imposed due to the actions of the Purchasers. 
 D.
Governmental Consents. No permit, consent, approval or authorization of, or declaration to or filing with, any governmental authority is required in connection with the execution, delivery and performance by the Company of this Agreement or
the consummation by the Company of any other transactions contemplated hereby. 
 E. Regulation D Qualification. Neither the Company
nor, to its actual knowledge, any of its affiliates, members, officers, directors or beneficial shareholders of 20% or more of its outstanding securities, has experienced a disqualifying event as enumerated pursuant to Rule 506(d) of Regulation D
under the Securities Act. 

  
 3 

 Section 3. Representations and Warranties of The Purchasers. As a material
inducement to the Company to enter into this Agreement and issue and sell the Private Placement Warrants to the Purchasers, the Purchasers hereby represent and warrant to the Company (which representations and warranties shall survive each Closing
Date) that: 
 A. Organization and Requisite Authority. The Purchasers possess all requisite power and authority necessary to carry
out the transactions contemplated by this Agreement. 
 B. Authorization; No Breach. 

(i) This Agreement constitutes a valid and binding obligation of the Purchasers, enforceable in accordance with its terms, subject to
bankruptcy, insolvency, fraudulent conveyance, reorganization, moratorium and other laws of general applicability relating to or affecting creditors’ rights and to general equitable principles (whether considered in a proceeding in equity or
law). 
 (ii) The execution and delivery and performance by the Purchasers of this Agreement and the fulfillment of and compliance with the
terms hereof and transaction contemplated hereunder by the Purchasers do not and shall not as of each Closing Date conflict with or result in a breach by the Purchasers of the terms, conditions or provisions of any agreement, instrument, order,
judgment or decree to which the Purchasers are subject. 
 C. Investment Representations. 

(i) The Purchasers are acquiring the Private Placement Warrants and, upon exercise of the Private Placement Warrants, the Ordinary Shares
issuable upon such exercise (collectively, the “Securities”), for the Purchasers’ own accounts, for investment purposes only and not with a view towards, or for resale in connection with, any public sale or distribution
thereof. 
 (ii) Each Purchaser is an “accredited investor” as such term is defined in Rule 501(a)(3) of Regulation D under the
Securities Act of 1933, as amended (the “Securities Act”), and each Purchaser has not experienced a disqualifying event as enumerated pursuant to Rule 506(d) of Regulation D under the Securities Act. 

(iii) The Purchasers understand that the Securities are being offered and will be sold to them in reliance on specific exemptions from the
registration requirements of the United States federal and state securities laws and that the Company is relying upon the truth and accuracy of, and the Purchasers’ compliance with, the representations and warranties of the Purchasers set forth
herein in order to determine the availability of such exemptions and the eligibility of the Purchasers to acquire such Securities. 
 (iv)
The Purchasers did not decide to enter into this Agreement as a result of any general solicitation or general advertising within the meaning of Rule 502(c) of Regulation D under the Securities Act. 

  
 4 

 (v) The Purchasers have been furnished with all materials relating to the business, finances
and operations of the Company and materials relating to the offer and sale of the Securities which have been requested by the Purchasers. The Purchasers have been afforded the opportunity to ask questions of the executive officers and directors of
the Company. The Purchasers understand that their investment in the Securities involves a high degree of risk and it has sought such accounting, legal and tax advice as it has considered necessary to make an informed investment decision with respect
to the acquisition of the Securities. 
 (vi) The Purchasers understand that no United States federal or state agency or any other government
or governmental agency has passed on or made any recommendation or endorsement of the Securities or the fairness or suitability of the investment in the Securities by the Purchasers nor have such authorities passed upon or endorsed the merits of the
offering of the Securities. 
 (vii) The Purchasers understand that: (a) the Securities have not been and are not being registered under
the Securities Act or any state securities laws, and may not be offered for sale, sold, assigned or transferred unless (1) in a registered transaction or (2) sold in reliance on an exemption therefrom; and (b) except as specifically
set forth in the Registration Rights Agreement, neither the Company nor any other person is under any obligation to register the Securities under the Securities Act or any state securities laws or to comply with the terms and conditions of any
exemption thereunder. In this regard, the Purchasers understand that the Securities and Exchange Commission (the “SEC”) has taken the position that promoters or affiliates of a blank check company and their transferees, both before
and after a Business Combination, are deemed to be “underwriters” under the Securities Act when reselling the securities of a blank check company. Based on that position, Rule 144 adopted pursuant to the Securities Act would not be
available for resale transactions of the Securities despite technical compliance with the requirements of such Rule, and the Securities can be resold only through a registered offering or in reliance upon another exemption from the registration
requirements of the Securities Act. While the Purchasers understand that Rule 144 is not available for the resale of securities initially issued by shell companies (other than business combination related shell companies) or issuers that have been
at any time previously a shell company, the Purchasers understand that Rule 144 includes an exception to this prohibition if the following conditions are met: (i) the issuer of the securities that was formerly a shell company has ceased to be a
shell company; (ii) the issuer of the securities is subject to the reporting requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”); (iii) the issuer of the securities
has filed all Exchange Act reports and material required to be filed, as applicable, during the preceding twelve (12) months (or such shorter period that the issuer was required to file such reports and materials), other than Form 8-K reports; and (iv) at least one (1) year has elapsed from the time that the issuer filed current Form 10 type information with the SEC reflecting its status as an entity that is not a shell company.

 (viii) The Purchasers have such knowledge and experience in financial and business matters, know of the high degree of risk associated
with investments in the securities of companies in the development stage such as the Company, are capable of evaluating the merits and risks of an investment in the Securities and are able to bear the economic risk of an investment in the Securities
in the amount contemplated hereunder for an indefinite period of time. The Purchasers have adequate means of providing for their current financial needs and contingencies and will have no current or anticipated future needs for liquidity which would
be jeopardized by the investment in the Securities. The Purchasers can afford a complete loss of their investments in the Securities. 

  
 5 

 (ix) The Purchasers understand that the Private Placement Warrants shall bear the legend
substantially in the form set forth in the Warrant Agreement. 
 Section 4. Conditions of the Purchasers’ Obligations. The
obligations of the Purchasers to purchase and pay for the Private Placement Warrants are subject to the fulfillment, on or before each Closing Date, of each of the following conditions: 

A. Representations and Warranties. The representations and warranties of the Company contained in Section 2 shall be true and
correct at and as of such Closing Date as though then made. 
 B. Performance. The Company shall have performed and complied with all
agreements, obligations and conditions contained in this Agreement that are required to be performed or complied with by it on or before such Closing Date. 

C. No Injunction. No litigation, statute, rule, regulation, executive order, decree, ruling or injunction shall have been enacted,
entered, promulgated or endorsed by or in any court or governmental authority of competent jurisdiction or any self-regulatory organization having authority over the matters contemplated hereby, which prohibits the consummation of any of the
transactions contemplated by this Agreement or the Warrant Agreement. 
 D. Warrant Agreement. The Company shall have entered into a
Warrant Agreement with a warrant agent on terms satisfactory to the Purchasers. 
 E. Corporate Consents. The Company shall have
obtained the consent of its board of directors authorizing the execution, delivery and performance of this Agreement and the Warrant Agreement and the issuance and sale of the Private Placement Warrants hereunder. 

Section 5. Conditions of the Company’s Obligations. The obligations of the Company to the Purchasers under this Agreement are
subject to the fulfillment, on or before each Closing Date, of each of the following conditions: 
 A. Representations and Warranties.
The representations and warranties of the Purchasers contained in Section 3 shall be true and correct at and as of such Closing Date as though then made. 

B. Performance. The Purchasers shall have performed and complied with all agreements, obligations and conditions contained in this
Agreement that are required to be performed or complied with by the Purchasers on or before such Closing Date. 
 C. No Injunction. No
litigation, statute, rule, regulation, executive order, decree, ruling or injunction shall have been enacted, entered, promulgated or endorsed by or in any court or governmental authority of competent jurisdiction or any self-regulatory organization
having authority over the matters contemplated hereby, which prohibits the consummation of any of the transactions contemplated by this Agreement or the Warrant Agreement. 

  
 6 

 D. Warrant Agreement. The Company shall have entered into a Warrant Agreement with a
warrant agent on terms satisfactory to the Company. 
 Section 6. Termination. This Agreement may be terminated at any time after
[•], 2021 upon the election by either the Company or the Purchasers upon written notice to the other party if the closing of the Public Offering does not occur prior to such date. 

Section 7. Survival of Representations and Warranties. All of the representations and warranties contained herein shall survive each
Closing Date. 
 Section 8. Definitions. Terms used but not otherwise defined in this Agreement shall have the meaning assigned to
such terms in the registration statement on Form S-1 the Company has filed with the SEC, under the Securities Act. 

Section 9. Miscellaneous. 

A. Successors and Assigns. Except as otherwise expressly provided herein, all covenants and agreements contained in this Agreement by or
on behalf of any of the parties hereto shall bind and inure to the benefit of the respective successors of the parties hereto whether so expressed or not. Notwithstanding the foregoing or anything to the contrary herein, the parties may not assign
this Agreement, other than assignments by the Purchasers to their affiliates thereof (including, without limitation, one or more of their members). Any transfer or assignment made other than as provided in this Section 9(A) shall be null and
void. 
 B. Severability. Whenever possible, each provision of this Agreement shall be interpreted in such manner as to be effective
and valid under applicable law, but if any provision of this Agreement is held to be prohibited by or invalid under applicable law, such provision shall be ineffective only to the extent of such prohibition or invalidity, without invalidating the
remainder of this Agreement. 
 C. Counterparts. This Agreement may be executed simultaneously in two or more counterparts, none of
which needs to contain the signatures of more than one party, but all such counterparts taken together shall constitute one and the same agreement. Signatures to this Agreement transmitted via facsimile or
e-mail in a “pdf” format data file shall be valid and effective to bind the party so signing with the same force and effect as if such facsimile or “pdf” signature page were an original
thereof. 
 D. Descriptive Headings; Interpretation. The descriptive headings of this Agreement are inserted for convenience only and
do not constitute a substantive part of this Agreement. The use of the word “including” in this Agreement shall be by way of example rather than by limitation. 

  
 7 

 E. Governing Law; Waiver of Jury Trial. This Agreement shall be deemed to be a
contract made under the laws of the State of New York and for all purposes shall be construed in accordance with the internal laws of the State of New York, without giving effect to conflicts of law principles that would result in the application of
the laws of another jurisdiction. All actions arising out of or relating to this Agreement shall be heard and determined exclusively in any New York federal court; provided, however, that if such federal court does not have jurisdiction over such
action, such action shall be heard and determined exclusively in any New York state court. The parties hereby irrevocably waive, and agree not to assert by way of motion, defense, or otherwise, in any action, any claim that it is not subject
personally to the jurisdiction of the above-named courts, that the action is brought in an inconvenient forum, that the venue of the action is improper, or that this Agreement or the transactions contemplated by this Agreement may not be enforced in
or by any of the above-named courts. EACH OF THE PARTIES HERETO HEREBY WAIVES TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW ANY RIGHT IT MAY HAVE TO A TRIAL BY JURY WITH RESPECT TO ANY LITIGATION DIRECTLY OR INDIRECTLY ARISING OUT OF, UNDER OR
IN CONNECTION WITH THIS AGREEMENT OR THE TRANSACTIONS CONTEMPLATED BY THIS AGREEMENT. 
 F. Amendments. This Agreement may not be
amended, modified or waived as to any particular provision, except by a written instrument executed by all parties hereto. 
 G. Waiver of
Claims Against Trust Account. The Purchasers agree not to seek recourse against the Trust Account for any reason whatsoever in connection with their purchase of the Private Placement Warrants or any claim that may arise now or in the future,
provided that nothing herein shall preclude the Purchasers from making any claim or seeking recourse against the Company’s funds held outside of the Trust Account. 

[Signature page follows] 

  
 8 

 IN WITNESS WHEREOF, the parties hereto have executed this Agreement to be effective
as of the date first set forth above. 
  

			
	COMPANY:
	GEFEN LANDA ACQUISITION CORP.
		
	By:	 	  

		 	Name: Elan Sigal
		 	Title: Chief Financial Officer
	
	PURCHASER:
	GEFEN LANDA HOLDINGS GP LLC for itself and as general partner of GEFEN LANDA HOLDINGS LP
		
	By:	 	  

		 	Name: Sheldon I. Stein
		 	Title: Manager
	
	PURCHASER:
	DBW HOLDINGS SPONSOR LP
		
	By:	 	  

		 	Name:
		 	Title:
	
	PURCHASER:
	LANDA VISION PARTNERS LP
		
	By:	 	  

		 	Name:
		 	Title:

 [Signature Page to Private Placement Warrants Purchase Agreement] 

 Exhibit A 

 

																	
	 Name
	  	Number
of
Private
Placement
Warrants
(No Exercise of
Over-allotment
Option)	 	  	Purchase Price
(No Exercise of
Over-allotment
Option)	 	  	Number of Private
Placement
Warrants
(Exercise of
Over-
allotment Option in
Full)	 	  	Purchase Price
(Exercise of Over-
allotment Option in
Full)	 
	 Gefen Landa Holdings LP
	  	 	1,733,333	 	  	$	2,600,000	 	  	 	1,900,001	 	  	$	2,850,000	 
	 DBW Holdings Sponsor LP
	  	 	1,466,667	 	  	$	2,200,000	 	  	 	1,633,333	 	  	$	2,450,000	 
	 Landa Vision Partners LP
	  	 	1,466,667	 	  	$	2,200,000	 	  	 	1,633,333	 	  	$	2,450,000	 
	 Total
	  	 	4,666,667	 	  	$	7,000,000	 	  	 	5,166,667	 	  	$	7,750,000EX-10.8

 Exhibit 10.8 

March [•], 2021 
 Gefen Landa Acquisition
Corp. 
 85 Medinat Hayehudim St., Building G, Floor 14 

Hertzliya, Israel 4676670 
  

	Re:	 Initial Public Offering 

Ladies and Gentlemen: 
 This letter (this
“Letter Agreement”) is being delivered to you in accordance with the Underwriting Agreement (the “Underwriting Agreement”) entered into by and between Gefen Landa Acquisition Corp., a Cayman Islands
exempted company (the “Company”), and BofA Securities, Inc. and Guggenheim Securities, LLC, as the representatives (the “Representatives”) of the several underwriters named therein (the
“Underwriters”), relating to an underwritten initial public offering (the “Public Offering”), of 28,750,000 of the Company’s units (including up to 3,750,000 units that may be purchased to cover
over-allotments, if any) (the “Units”), each comprised of one Class A ordinary share of the Company, par value $0.0001 per share (each, an “Ordinary Share”), and
one-third of one redeemable warrant (each whole warrant, a “Warrant”). Each Warrant entitles the holder thereof to purchase one Ordinary Share at a price of $11.50 per share, subject to
adjustment. The Units shall be sold in the Public Offering pursuant to a registration statement on Form S-1 and prospectus (the “Prospectus”) filed by the Company with the Securities
and Exchange Commission (the “Commission”). Certain capitalized terms used herein are defined in paragraph 11 hereof. 

In order to induce the Company and the Underwriters to enter into the Underwriting Agreement and to proceed with the Public Offering and for
other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, Gefen Landa Holdings LP, a Cayman Islands exempted limited partnership, DBW Holdings Sponsor LP, an Israeli limited partnership and Landa Vision
Partners LP, an Israeli limited partnership (each a “Sponsor”, and collectively, the “Sponsors”), and each of the undersigned individuals, each of whom is a member of the Company’s board of
directors and/or management team (each, an “Insider” and collectively, the “Insiders”), each hereby agrees, severally but not jointly, with the Company as follows: 

1. Business Combination Vote. The Sponsors and each Insider agree with the Company that if the Company seeks shareholder approval
of a proposed initial Business Combination, then in connection with such proposed initial Business Combination, they, it, she or he as applicable, shall (i) vote any Shares owned by them, it, her or him in favor of any proposed Business
Combination (including any proposals recommended by the Company’s board of directors in connection with such Business Combination) and (ii) not redeem any Shares owned by them, it, her or him in connection with such shareholder approval.
If the Company engages in a tender offer in connection with any proposed initial Business Combination, the Sponsors and each Insider, with respect to themselves, itself, herself or himself, agree that they, it, she or he will not seek to sell their,
its, his or her Ordinary Shares to the Company in connection with such tender offer. 

 2. Failure to Consummate a Business Combination. The Sponsors and each Insider
hereby agree with the Company that, in the event that the Company fails to consummate a Business Combination within 24 months from the closing of the Public Offering, or such later period approved by the Company’s shareholders in accordance
with the Company’s amended and restated memorandum and articles of association, as amended from time to time, the Sponsors and each Insider shall take all reasonable steps to cause the Company to (i) cease all operations except for the
purpose of winding up, (ii) as promptly as reasonably possible but not more than ten (10) business days thereafter, redeem 100% of the Offering Shares, at a per share price, payable in cash, equal to the aggregate amount then on deposit in
the Trust Account, including interest earned on the funds held in the Trust Account and not previously released to the Company to pay income taxes (less up to $100,000 of interest to pay dissolution expenses and which interest shall be net of taxes
payable, expenses relating to the administration of the Trust Account and limited withdrawals for working capital), divided by the number of then issued and outstanding Offering Shares, which redemption will completely extinguish the Public
Shareholders’ rights as shareholders (including the right to receive further liquidating distributions, if any), subject to applicable law, and (iii) as promptly as reasonably possible following such redemption, subject to the approval of
the Company’s remaining shareholders and the Company’s board of directors, liquidate and dissolve, subject in each case to the Company’s obligations under Cayman Islands law to provide for claims of creditors and the requirements of
other applicable law. The Sponsors and each Insider agree not to propose any amendment to the Company’s amended and restated memorandum and articles of association (a) to modify the substance or timing of the Company’s obligation to
allow redemption in connection with the Company’s initial Business Combination or to redeem 100% of the Offering Shares if the Company does not complete its initial Business Combination within 24 months from the closing of the Public Offering,
or (b) with respect to any other provision relating to shareholders’ rights or pre-initial Business Combination activity, unless the Company provides its Public Shareholders with the opportunity to
redeem their Offering Shares upon approval of any such amendment at a per share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned (which interest shall be net of taxes payable,
expenses relating to the administration of the trust account and limited withdrawals for working capital) on the funds held in the Trust Account and not previously released to the Company to pay income taxes, if any, divided by the number of then
issued and outstanding Offering Shares. The Sponsors and each Insider agree to waive each of their respective redemption rights with respect to the Founder Shares and Offering Shares owned by them in connection with a shareholder vote to approve an
amendment to the Articles (x) that would modify the substance or timing of the Company’s obligation to allow redemption in connection with its initial Business Combination or to redeem 100% of the Offering Shares if the Company does not
complete an initial Business Combination within the required time period set forth in the Articles or (y) with respect to any provision relating to the rights of holders of Offering Shares or pre-initial
Business Combination activity. 
 3. Trust Account Waiver. The Sponsors and each Insider, with respect to themselves, itself,
herself or himself, acknowledges that they, it, he or she has no right, title, interest or claim of any kind in or to any monies held in the Trust Account or any other asset of the Company as a result of any liquidation of the Company with respect
to the Founder Shares held by them, it, her or him, if any. The Sponsors and each Insider hereby further waive, with respect to any Shares held by them, it, him or her, if any, any redemption rights they, it, he or she may have in connection with
(x) the consummation of its Business Combination, including, without limitation, any such 

  
 - 2 - 

 
rights available in the context of a shareholder vote to approve such Business Combination or in the context of a tender offer made by the Company to purchase Ordinary Shares and (y) a
shareholder vote to amend the Company’s amended and restated memorandum and articles of association (i) to modify the substance or timing of the Company’s obligation to allow redemption in connection with the Company’s initial
Business Combination or to redeem 100% of the Offering Shares if the Company does not complete its initial Business Combination within 24 months from the closing of the Public Offering, or (ii) with respect to any other provision relating to
shareholders’ rights or pre-initial Business Combination activity (although the Sponsors and the Insiders shall be entitled to redemption and liquidating distributions with respect to any Offering Shares
it or they hold if the Company fails to consummate its Business Combination within the required time period set forth in the Articles). 

4. Indemnification. In the event of the liquidation of the Trust Account, the Sponsors (which for purposes of clarification shall
not extend to any other shareholders, partners, members or managers of the Sponsors) (the “Indemnitors”) agree to indemnify and hold harmless the Company against any and all loss, liability, claim, damage and expense
whatsoever (including, but not limited to, any and all legal or other expenses reasonably incurred in investigating, preparing or defending against any litigation, whether pending or threatened) to which the Company may become subject as a result of
any claim by (i) any third party for services rendered or products sold to the Company (other than the Company’s independent auditors) or (ii) a prospective target business with which the Company has entered into a written letter of
intent, confidentiality or other similar agreement or business combination agreement (a “Target”); provided, however, that such indemnification of the Company by the Indemnitors (x) shall apply only to the
extent necessary to ensure that such claims by a third party for services rendered (other than the Company’s auditors) or products sold to the Company or a Target do not reduce the amount of funds in the Trust Account to below the lesser of (A)
$10.00 per Offering Share or (B) the actual amount per Offering Share held in the Trust Account as of the date of the liquidation of the Trust Account if less than $10.00 per Offering Share due to reductions in the value of the trust assets, in
each case, net of interest that may be withdrawn to pay the Company’s tax obligations, (y) shall not apply to any claims by a third party or Target who executed a waiver of any and all rights to seek access to the monies held in the Trust
Account (whether or not such waiver is enforceable) and (z) shall not apply to any claims under the Company’s indemnity of the Underwriters against certain liabilities, including liabilities under the Securities Act of 1933, as amended.
The Indemnitors shall have the right to defend against any such claim with counsel of their choice reasonably satisfactory to the Company if, within 15 days following written receipt of notice of the claim to the Indemnitors, the Indemnitors notify
the Company in writing that they shall undertake such defense. For the avoidance of doubt, none of the Company’s officers or directors are Indemnitors subject to this Section 4. 

5. Forfeiture of Founder Shares. To the extent that the Underwriters do not exercise their over-allotment option to purchase up
to 3,750,000 additional Units within 45 days from the date of the Prospectus in full or in part (as further described in the Prospectus), each of the Sponsors agree to automatically surrender to the Company for no consideration, for cancellation at
no cost, an aggregate number of Founder Shares (as allocated among the Sponsors as set forth on Exhibit A) so that the number of Founder Shares that remains outstanding after such forfeiture will equal 20.0% of the sum of the total number of
Ordinary Shares and Founder Shares outstanding at such time. The Initial Shareholders further agree that to the extent that the size of the Public Offering is increased or decreased, the Company will effect a capitalization or a share repurchase or
redemption, as applicable, with respect to the Founder Shares immediately prior to the consummation of the Public Offering in such amount as to maintain the number of Founder Shares at 20.0% of the sum of the total number of Ordinary Shares
outstanding at such time. 

  
 - 3 - 

 6. Remedies. The Sponsors and each Insider hereby agree and acknowledge that:
(i) the Underwriters and the Company would be irreparably injured in the event of a breach by such Sponsors or Insider of their, its, his or her obligations under paragraphs 1, 2, 3, 4, 5, 7(a), 7(b), and 9 of this Letter Agreement,
(ii) monetary damages may not be an adequate remedy for such breach and (iii) the non-breaching party shall be entitled to seek injunctive relief, in addition to any other remedy that such party may
have in law or in equity, in the event of such breach. 
 7. Lock-up; Transfer
Restrictions. 
 (a) The Sponsors and each Insider agree that they, it, he or she shall not Transfer (as defined below) any Founder
Shares (or Ordinary Shares issuable upon conversion thereof) until the earlier of (A) one year after the completion of the Company’s initial Business Combination and (B) subsequent to the Business Combination, (x) if the last
reported sale price of the Ordinary Shares equals or exceeds $12.00 per share (as adjusted for share sub-divisions, share dividends, rights issuances, consolidations, reorganizations, recapitalizations and the
like) for any 20 trading days within any 30-trading day period commencing at least 150 days after the Company’s initial Business Combination or (y) the date following the completion of the
Company’s initial Business Combination on which the Company completes a liquidation, merger, amalgamation, share exchange, reorganization or other similar transaction that results in all of the Public Shareholders having the right to exchange
their Ordinary Shares for cash, securities or other property (the “Founder Shares Lock-up Period”). 

(b) The Sponsors and each Insider agree that they, it, he or she shall not Transfer any Private Placement Warrants (or Ordinary Shares issued
or issuable upon the exercise or conversion of the Private Placement Warrants) until 30 days after the completion of the Company’s initial Business Combination (the “Private Placement Warrants
Lock-up Period”, and together with the Founder Shares Lock-up Period, the “Lock-up
Periods”). 
 (c) Notwithstanding the provisions set forth in paragraphs 7(a) and 7(b), Transfers of the Founder Shares, Private
Placement Warrants and Ordinary Shares issued or issuable upon the exercise or conversion of the Private Placement Warrants or the Founder Shares and that are held by the Sponsors, any Insider or any of their permitted transferees (that have
complied with the provisions of this paragraph 7(c)) are permitted (i) to the Company’s directors or officers, any affiliates or family members or partners of the Company’s directors or officers, and to any members or partners of the
Sponsors or any affiliates of the Sponsors; (ii) in the case of an individual, by gift to a member of the individual’s immediate family, or to a trust, the beneficiary of which is a member of the individual’s immediate family or an
affiliate of such person, or to a charitable organization; (iii) in the case of an individual, by virtue of laws of descent and distribution upon death of the individual; (iv) in the case of an individual, pursuant to a qualified domestic
relations order; (v) by private sales or transfers made in connection with the consummation of the Company’s Business Combination at prices no greater than the price at which the Founder Shares, Private Placement Warrants or Ordinary
Shares, as applicable, were originally 

  
 - 4 - 

 
purchased; (vi) in the event of the Company’s liquidation prior to the Company’s completion of its initial Business Combination; (vii) by virtue of the laws of the State of
Delaware or the Sponsors’ organizational documents, upon dissolution of each of our Sponsors; and (viii) in the event of the Company’s completion of a liquidation, merger, amalgamation, share exchange, reorganization or other similar
transaction which results in all of the Company’s shareholders having the right to exchange their Ordinary Shares for cash, securities or other property subsequent to the completion of the Company’s initial Business Combination;
provided, however, that, in the case of clauses (i) through (v) or (vii), these permitted transferees must enter into a written agreement with the Company agreeing to be bound by these transfer restrictions and any other
restrictions contained in this Letter Agreement and by the same agreements entered into by the Sponsors with respect to such securities (including provisions relating to voting, the Trust Account and liquidating distributions). 

(d) Notwithstanding the provisions set forth in paragraphs 7(a) and 7(b), during the period commencing on the effective date of the
Underwriting Agreement and ending 180 days after such date, the Sponsors and each Insider shall not, without the prior written consent of the Representatives, offer, sell, contract to sell, pledge or otherwise dispose of (or enter into any
transaction that is designed to, or might reasonably be expected to, result in the disposition of (whether by actual disposition or effective economic disposition due to cash settlement or otherwise)), directly or indirectly, or establish or
increase a put equivalent position or liquidate or decrease a call equivalent position within the meaning of Section 16 (“Section 16”) of the Securities Exchange Act of 1934, as amended,
and the rules and regulations of the Commission promulgated thereunder, with respect to, any Units, Shares, Warrants or any securities convertible into, or exercisable, or exchangeable for, Ordinary Shares, or publicly announce an intention to
effect any such transaction; provided, however, that the foregoing does not apply to the forfeiture of any Founder Shares pursuant to their terms or any Transfer of Founder Shares to any current or future independent director or
officer of the Company (as long as such current or future independent director or officer Transferee is subject to this Letter Agreement or executes an agreement substantially identical to the terms of this Letter Agreement, as applicable to
directors and officers at the time of such Transfer; and as long as, to the extent any Section 16 reporting obligation is triggered as a result of such Transfer, any related Section 16 filing includes a practical explanation as to the
nature of the Transfer). The Sponsors and each of the Insiders acknowledge and agree that, prior to the effective date of any release or waiver, of the restrictions set forth in this paragraph 7(d) or paragraph 7(a) above, the Company may announce
the impending release or waiver by press release through a major news service at least two business days before the effective date of such release or waiver. Any release or waiver granted shall only be effective two business days after the
publication date of such press release. The provisions of this paragraph will not apply if the release or waiver is effected solely to permit a Transfer not for consideration and the Transferee has agreed in writing to be bound by the same terms
described in this Letter Agreement to the extent and for the duration that such terms remain in effect at the time of the Transfer. 
 8.
Representations and Warranties. 
 (a) The Sponsors and each Insider represent and warrant that they, it, she or he have never
been suspended or expelled from membership in any securities or commodities exchange or association or had a securities or commodities license or registration denied, 

  
 - 5 - 

 
suspended or revoked. Each Insider’s biographical information furnished to the Company, if any (including any such information included in the Prospectus), is true and accurate in all
respects and does not omit any material information with respect to such Insider’s background. Each Insider’s questionnaire furnished to the Company, if any, and the Representatives is true and accurate in all respects. Each Insider
represents and warrants that: (i) it, she or he is not subject to, or a respondent in, any legal action for, any injunction, cease-and-desist order or order or
stipulation to desist or refrain from any act or practice relating to the offering of securities in any jurisdiction, (ii) nor has it, she or he ever been convicted of, or pleaded guilty to, any crime (A) involving fraud, (B) relating
to any financial transaction or handling of funds of another person, or (C) pertaining to any dealings in any securities, and (iii) it, she or he is not currently a defendant in any such criminal proceeding. 

(b) Each Sponsor and each Insider has full right and power, without violating any agreement to which it, she, or he is bound (including,
without limitation, any non-competition or non-solicitation agreement with any employer or former employer), to enter into this Letter Agreement and, as applicable, to
serve as a director on the board of directors of the Company and hereby consents to being named in the Prospectus as a director of the Company. 

9. Payments by the Company. 

(a) Except as disclosed in, or as expressly contemplated by, the Prospectus, neither the Sponsors nor any Insider nor any affiliate of the
Sponsors or any Insider, nor any director or officer of the Company, nor any affiliate of the directors and officers, shall receive from the Company any finder’s fee, reimbursements or other cash payments (such as private placement advisory
services fees or other material fees) for services rendered to the Company prior to or in connection with the completion of the Company’s initial Business Combination, other than for the following payments, and for the sale of the private
placement warrants held in the trust account prior to the completion of the Company’s initial Business Combination: (i) repayment of an aggregate of up to $300,000 in loans made to us by one of our sponsors to cover offering-related and
organizational expenses, (ii) payment to an affiliate of one of our Sponsors of a total of $10,000 per month for office space, administrative and support services (including salaries). (iii) reimbursement for any
out-of-pocket expenses related to identifying, investigating and completing an initial Business Combination (excluding for the avoidance of doubt any success or
finders’ fee or any private placement advisory services fees or other material fees) and (iv) repayment of loans which may be made by the Sponsors or an affiliate of one of the Sponsors or certain of the Company’s officers and
directors to finance transaction costs in connection with an intended initial Business Combination, the terms of which have not been determined nor have any written agreements been executed with respect thereto; provided, that, if the Company
does not consummate an initial Business Combination, a portion of the working capital held outside the Trust Account may be used by the Company to repay such loaned amounts so long as no proceeds from the Trust Account are used for such repayment.
Up to $1,500,000 of such loans may be convertible into warrants, at a price of $1.50 per warrant at the option of the lender. 
 (b)
Commencing on the effective date of the Prospectus for the Public Offering and continuing until the earlier of (i) the consummation by the Company of its initial Business Combination or (ii) the Company’s liquidation as described in
the Prospectus, the Sponsors shall make available to the Company, in an amount not to exceed $10,000 per month, certain office space, utilities and secretarial and administrative support services as may be required by the Company from time to time,
situated at 85 Medinat Hayehudim St., Building G, Floor 14, Hertzliya, Israel 4676670 (or any successor location(s)). 

  
 - 6 - 

 10. Definitions. As used herein: 

(a) “Business Combination” shall mean a merger, amalgamation, share exchange, asset acquisition, share purchase,
reorganization or similar business combination, involving the Company and one or more businesses; 
 (b) “Founder
Shares” shall mean the 7,187,500 Class B ordinary shares, par value $0.0001 per share, issued and outstanding immediately prior to the consummation of the Public Offering; 

(c) “Initial Shareholders” shall mean the Sponsors and any other person that holds Founder Shares; 

(d) “Offering Shares” shall mean Ordinary Shares included in the Units issued in the Public Offering; 

(e) “Private Placement Warrants” shall mean the Warrants to purchase an aggregate of 4,666,667 Ordinary Shares of the
Company (or up to 5,166,667 Ordinary Shares of the Company depending on the extent to which the Underwriters’ over-allotment option is exercised pursuant to the Underwriting Agreement) that the Sponsors have agreed to purchase for an aggregate
purchase price of $7,000,000 (or up to $7,750,000 depending on the extent to which the Underwriters’ over-allotment option is exercised pursuant to the Underwriting Agreement), or $1.50 per Warrant, in a private placement that shall occur
simultaneously with the consummation of the Public Offering; 
 (f) “Public Shareholders” shall mean the holders of
securities issued in the Public Offering; 
 (g) “Shares” shall mean, collectively, the Ordinary Shares and the
Founder Shares; 
 (h) “Trust Account” shall mean the trust account into which the net proceeds of the Public
Offering shall be deposited; and 
 (i) “Transfer” shall mean the (i) sale of, offer to sell, contract or
agreement to sell, hypothecate, pledge, grant of any option to purchase or otherwise dispose of or agreement to dispose of, directly or indirectly, or establishment or increase of a put equivalent position or liquidation with respect to or decrease
of a call equivalent position within the meaning of Section 16 and the rules and regulations of the Commission promulgated thereunder with respect to, any security, (ii) entry into any swap or other arrangement that transfers to another,
in whole or in part, any of the economic consequences of ownership of any security, whether any such transaction is to be settled by delivery of such securities, in cash or otherwise, or (iii) public announcement of any intention to effect any
transaction specified in clause (i) or (ii). 

  
 - 7 - 

 11. Entire Agreement. This Letter Agreement constitutes the entire agreement
and understanding of the parties hereto in respect of the subject matter hereof and supersedes all prior understandings, agreements, or representations by or among the parties hereto, written or oral, to the extent they relate in any way to the
subject matter hereof or the transactions contemplated hereby. This Letter Agreement may not be changed, amended, modified or waived (other than to correct a typographical error) as to any particular provision, except by a written instrument
executed by (1) each Insider that is the subject of any such change, amendment, modification or waiver and (2) the Sponsors. 

12. Neutral Construction. The parties agree that this Letter Agreement was negotiated at
arm’s-length and that the final terms hereof are the product of the parties’ negotiations. This Letter Agreement will be deemed to have been jointly and equally drafted by both parties, and the
provisions hereof will not be construed against a party on the grounds that the party drafted or was more responsible for drafting the provision. 

13. Assignment. No party hereto may assign either this Letter Agreement or any of its rights, interests, or obligations hereunder
without the prior written consent of the other party. Any purported assignment in violation of this paragraph 13 shall be void and ineffectual and shall not operate to transfer or assign any interest or title to the purported assignee. This Letter
Agreement shall be binding on the Sponsors and each Insider and their respective successors, heirs and assigns and permitted Transferees. 

14. No Third Party Beneficiaries. Nothing in this Letter Agreement shall be construed to confer upon, or give to, any person or
corporation other than the parties hereto any right, remedy or claim under or by reason of this Letter Agreement or of any covenant, condition, stipulation, promise or agreement hereof. All covenants, conditions, stipulations, promises and
agreements contained in this Letter Agreement shall be for the sole and exclusive benefit of the parties hereto and their successors, heirs, personal representatives and assigns and permitted Transferees. 

15. Severability. This Letter Agreement shall be deemed severable, and the invalidity or unenforceability of any term or
provision hereof shall not affect the validity or enforceability of this Letter Agreement or of any other term or provision hereof. Furthermore, in lieu of any such invalid or unenforceable term or provision, the parties hereto intend that there
shall be added as a part of this Letter Agreement a provision as similar in terms to such invalid or unenforceable provision as may be possible and that it shall be deemed valid and enforceable. 

16. Governing Law. This Letter Agreement shall be governed by and construed and enforced in accordance with the laws of the State
of New York, without giving effect to conflicts of law principles that would result in the application of the substantive laws of another jurisdiction. The parties hereto (i) all agree that any action, proceeding, claim or dispute arising out
of, or relating in any way to, this Letter Agreement shall be brought and enforced in the courts of New York City, in the State of New York, and irrevocably submit to such jurisdiction and venue, which jurisdiction and venue shall be exclusive and
(ii) waive any objection to such exclusive jurisdiction and venue or that such courts represent an inconvenient forum. 

  
 - 8 - 

 17. Waiver of Jury Trial. THE PARTIES TO THIS LETTER AGREEMENT EACH HEREBY
WAIVES, TO THE FULLEST EXTENT PERMITTED BY LAW, ANY RIGHT TO TRIAL BY JURY OF ANY CLAIM, DEMAND, ACTION OR CAUSE OF ACTION (A) ARISING UNDER THIS LETTER AGREEMENT OR (B) IN ANY WAY CONNECTED WITH OR RELATED OR INCIDENTAL TO THE DEALINGS OF
THE PARTIES HERETO IN RESPECT OF THIS LETTER AGREEMENT OR ANY OF THE TRANSACTIONS RELATED HERETO, IN EACH CASE WHETHER NOW EXISTING OR HEREAFTER ARISING, AND WHETHER IN CONTRACT, TORT, EQUITY OR OTHERWISE. THE PARTIES TO THIS LETTER AGREEMENT EACH
HEREBY AGREES AND CONSENTS THAT ANY SUCH CLAIM, DEMAND, ACTION OR CAUSE OF ACTION SHALL BE DECIDED BY COURT TRIAL WITHOUT A JURY, AND THAT THE PARTIES TO THIS LETTER AGREEMENT MAY EACH FILE A COPY OF THIS LETTER AGREEMENT WITH ANY COURT AS WRITTEN
EVIDENCE OF THE CONSENT OF THE PARTIES HERETO TO THE WAIVER OF THEIR RESPECTIVE RIGHT TO TRIAL BY JURY. 
 18. Notices. Any
notice, consent or request to be given in connection with any of the terms or provisions of this Letter Agreement shall be in writing and shall be sent by express mail or similar private courier service, by certified mail (return receipt requested),
by hand delivery or facsimile or other electronic transmission. 
 19. Liability. Each party hereto shall not be liable for any
breaches or misrepresentations contained in this Letter Agreement by any other party to this Letter Agreement, and no party shall be liable or responsible for the obligations of another party, including, without limitation, indemnification
obligations and notice obligations. 
 20. Termination. This Letter Agreement shall terminate on the earlier of (i) the
expiration of the Lock-up Periods or (ii) the liquidation of the Company; provided, however, that this Letter Agreement shall earlier terminate in the event that the Public Offering is not
consummated and closed by June 31, 2021; provided, further that paragraph 4 of this Letter Agreement shall survive such liquidation. 

21. No Joint and Several Liability. Notwithstanding anything that may be express or implied in this Letter Agreement, the
obligations of each Sponsor and each Insider hereunder shall be several and not joint. Accordingly, in the event of a breach of this Letter Agreement by any of the Sponsors or any Insider (the “Breaching Party”), no other
person other than the Breaching Party shall have any liability for any obligations or liabilities hereunder with respect to any claims, obligations, liabilities, or causes of action (whether in contract or in tort, in law or in equity, or granted by
statute) arising out of, or in connection with, a breach by the Breaching Party under this Letter Agreement. 
 22.
Counterparts. This Letter Agreement may be executed in any number of original or facsimile counterparts and each of such counterparts shall for all purposes be deemed to be an original, and all such counterparts shall together constitute
but one and the same instrument. 
 [Signature pages follow] 

  
 - 9 - 

 
					
	Sincerely,
	GEFEN LANDA HOLDINGS LP
	
	 BY: GEFEN LANDA HOLDINGS GP LLC,

THE GENERAL PARTNER 

		
	By:	 	      

		 	Name:	 	Sheldon I. Stein
		 	Title:	 	Manager of Gefen Landa Holdings GP LLC
	
	DBW HOLDINGS SPONSOR LP
		
	By:	 	      

		 	Name:	 	David Wiessman
		 	Title:	 	Director
	
	LANDA VISION PARTNERS LP
		
	By:	 	      

		 	Name:	 	Benzion Landa
		 	Title:	 	Sole Shareholder

  

	
	          

	Name: Benzion Landa

  

	
	      

	Name: David Wiessman

  

	
	  

	Name: Kathleen Mason

  

	
	          

	Name: Eddy Shalev

  

	
	          

	Name: David Glaser

  

	
	          

	Name: David Lee

  

	
	          

	Name: Elan Sigal

  

	
	          

	 Name: Sheldon I. Stein

  

					
	Acknowledged and Agreed:
	GEFEN LANDA ACQUISITION CORP.
		
	By:	 	              

		 	Name: Sheldon I. Stein
		 	Title: Chief Executive Officer

  
 [Signature Page to
Letter Agreement] 

 Exhibit A 

Founder Shares 
  

																	
	 Entity
	  	Founder
Shares	 	  	Founder
Warrants	 	  	Founder Shares
with Over-allotment	 	  	Founder Warrants
with Over-allotment	 
	 Landa Vision Partners LP
	  	 	1,931,286	 	  	 	1,466,667	 	  	 	2,243,786	 	  	 	1,633,333	 
	 DBW Holdings Sponsor LP
	  	 	1,931,286	 	  	 	1,466,667	 	  	 	2,243,786	 	  	 	1,633,333	 
	 Gefen Landa Holdings LP
	  	 	2,382,428	 	  	 	1,733,333	 	  	 	2,694,928	 	  	 	1,900,001	 
	 Elan Sigal
	  	 	5,000	 	  	 	0	 	  	 	5,000	 	  	 	0	 
		  	  
	  
	 	  	  
	  
	 	  	  
	  
	 	  	  
	  
	 
	 Total
	  	 	6,250,000	 	  	 	4,666,667	 	  	 	7,187,500	 	  	 	5,166,667	 
		  	  
	  
	 	  	  
	  
	 	  	  
	  
	 	  	  
	  
	 

  
 [Signature Page to
Letter Agreement]

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00324-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00324-of-00352.parquet"}]]